References
- RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
- FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
- DonaldsonGCSeemungalTAPatelISAirway and systemic inflammation and decline in lung function in patients with COPDChest200512841995200416236847
- WilkinsonTMPatelISWilksMDonaldsonGCWedzichaJAAirway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200316781090109512684248
- O’DonnellRAPeeblesCWardJARelationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPDThorax2004591083784215454648
- KanazawaHHirataKYoshikawaJAccelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patientsChest2003123259659912576384
- StănescuDSannaAVeriterCAirways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophilsThorax19965132672718779129
- TuratoGZuinRMiniatiMAirway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysemaAm J Respir Crit Care Med2002166110511012091179
- HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
- BanerjeeDKhairOAHoneybourneDImpact of sputum bacteria on airway inflammation and health status in clinical stable COPDEur Respir J200423568569115176680
- BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
- PatelISSeemungalTAWilksMLloyd-OwenSJDonaldsonGCWedzichaJARelationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbationsThorax200257975976412200518
- PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med2006173101114112116484677
- WhiteAJGompertzSBayleyDLResolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitisThorax200358868068512885984
- HillATCampbellEJHillSLBayleyDLStockleyRAAssociation between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitisAm J Med2000109428829510996579
- MarinAMonsóEGarcia-NuñezMVariability and effects of bronchial colonisation in patients with moderate COPDEur Respir J201035229530219643939
- PavordIDSterkPJHargreaveFEClinical applications of assessment of airway inflammation using induced sputumEur Respir J Suppl20023740s43s12361362
- PizzichiniEPizzichiniMMEfthimiadisAIndices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurementsAm J Respir Crit Care Med19961542 Pt 13083178756799
- BrightlingCEMonterioWGreenRHInduced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatabilityRespir Med20019512999100211778799
- Health Protection AgencyInvestigation of bronchoalveolar lavage, sputum and associated specimensNational Standard Method BSOP 57 Issue 2.3|| Available from: http//www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317132860548Accessed on November 12, 2013
- PyeAStockleyRAHillSLSimple method for quantifying viable bacterial numbers in sputumJ Clin Pathol19954887197247560197
- StockleyRAO’BrienCPyeAHillSLRelationship of sputum color to nature and outpatient management of acute exacerbations of COPDChest200011761638164510858396
- StockleyRAHillATHillSLCampbellEJBronchial inflammation: its relationship to colonizing microbial load and alpha(1)-antitrypsin deficiencyChest20001175 Suppl 1291S293S10843958
- StockleyRAHillSLMorrisonHMEffect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical stateThorax19843964144196611601
- SethiSJonesPWTheronMSPULSE Study groupPulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialRespir Res2010111020109213
- AlbertRKConnettJBaileyWCCOPD Clinical Research NetworkAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
- LodeHAlleweltMRole of newer fluoroquinolones in lower respiratory tract infectionsJ Antimicrob Chemother200249570971212003962
- TakizawaHDesakiMOhtoshiTErythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cellsAm J Respir Crit Care Med199715612662719230759
- KadirTIzzetinFVCevikbasşAJohanssonCBClarkPIn vitro effects of clarithromycin on human polymorphonuclear leukocyte functionsChemotherapy200046319820310765036
- WilsonRAllegraLHuchonGMOSAIC Study GroupShort-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitisChest2004125395396415006954
- WilsonRAnzuetoAMiravitllesMMoxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL resultsEur Respir J2012401172722135277